Topotecan
- Product NDC
- 0409-0302
- 11-digit product format
- 004090302
- Labeler code
- 0409
- Product ID
- 0409-0302_293334d4-88f2-4ec2-9eed-20975ff65c0a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- TOPOTECAN
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Hospira, Inc.
- Application
- NDA200582
- Marketing category
- NDA
- Marketing start
- 2011-02-21
- Substance
- TOPOTECAN HYDROCHLORIDE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Topotecan
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TOPOTECAN HYDROCHLORIDE | 1 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 956S425ZCY |
| Rxcui | 1799424 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0409-0302-01 | Topotecan | 4 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 4 | | 23 |
| 0409-0302-01 | Topotecan | 1 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 1 | | 23 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| TOPOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 956S425ZCY | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 16 | |
| TOPOTECAN | ACTIVE MOIETY | 7M7YKX2N15 | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 16 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 16 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 16 | |
| TARTARIC ACID | INACTIVE INGREDIENT | W4888I119H | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 16 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 16 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0409-0302 | TOPOTECAN INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 23 | Current NDC, Legacy NDC, 2 package rows | 20210203_1d4e1cce-c57e-4a8b-be96-f95a2778e221.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0409-0302-01 | 00409030201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0302-01) / 4 mL in 1 VIAL, SINGLE-DOSE | 2011-02-21 | 0000-00-00 | No | No | Current |